DE LUCA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 124
EU - Europa 94
AS - Asia 62
SA - Sud America 17
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 300
Nazione #
US - Stati Uniti d'America 123
RU - Federazione Russa 45
SG - Singapore 39
IT - Italia 28
BR - Brasile 17
CN - Cina 11
IE - Irlanda 9
HK - Hong Kong 5
DE - Germania 4
TR - Turchia 4
FR - Francia 3
FI - Finlandia 2
SE - Svezia 2
BD - Bangladesh 1
CA - Canada 1
IL - Israele 1
KE - Kenya 1
PL - Polonia 1
TZ - Tanzania 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 300
Città #
Ashburn 24
Singapore 18
Chandler 17
Princeton 11
Dublin 9
Ann Arbor 7
Turin 7
Moscow 6
Boardman 5
Hong Kong 5
Washington 5
Council Bluffs 4
Izmir 3
Monteforte Irpino 3
Nuremberg 3
Andover 2
Belo Horizonte 2
Fairfield 2
Jacksonville 2
Lappeenranta 2
Naples 2
Norwalk 2
Partinico 2
Rome 2
Salerno 2
Shenzhen 2
São Paulo 2
Wilmington 2
Artur Nogueira 1
Bareggio 1
Boston 1
Calçado 1
Camaçari 1
Castanhal 1
Changsha 1
Dallas 1
Ferizaj 1
Florence 1
Hangzhou 1
Huddinge 1
Istanbul 1
Los Angeles 1
Maricá 1
Montreal 1
Nairobi 1
Paris 1
Porto Alegre 1
Raul Soares 1
Recife 1
Redwood City 1
Rennes 1
Ribeirão Preto 1
Rio das Ostras 1
San Diego 1
Schio 1
Schroeder 1
Seattle 1
Shakhty 1
Stone Town 1
Tabuleiro do Norte 1
Tashkent 1
Torres 1
Warsaw 1
Weihai 1
Xi'an 1
Totale 190
Nome #
Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients 46
Meta-Analysis Comparing Outcomes After Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients with Acute Coronary Syndromes 43
Impact of renal dysfunction and acute kidney injury on outcome in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention 40
Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets 36
Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes 26
Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry 22
Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry 20
Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach-Where Do We Stand? 19
Angiographic and clinical outcome of SARS-CoV-2 positive patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: A collaborative, individual patient data meta-analysis of six registry-based studies 17
Editorial: Advances in Percutaneous Coronary Intervention 16
SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical Reperfusion 13
Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention 12
Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions 8
Impact of hypertension on mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty: insights from the international multicenter ISACS-STEMI registry 1
Totale 319
Categoria #
all - tutte 2.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 3 1
2020/20218 0 0 0 0 0 1 0 1 1 1 3 1
2021/202221 0 0 0 0 1 0 3 0 3 3 2 9
2022/202357 3 5 3 4 15 12 0 2 6 3 2 2
2023/202492 2 13 13 3 8 17 0 5 0 10 2 19
2024/2025122 0 3 2 5 10 16 38 9 24 15 0 0
Totale 319